136 related articles for article (PubMed ID: 28351200)
1. Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease.
Wyman-Chick KA; Martin PK; Barrett MJ; Manning CA; Sperling SA
J Geriatr Psychiatry Neurol; 2017 May; 30(3):178-183. PubMed ID: 28351200
[TBL] [Abstract][Full Text] [Related]
2. Screening for Cognitive Impairment in Parkinson's Disease: Improving the Diagnostic Utility of the MoCA through Subtest Weighting.
Fengler S; Kessler J; Timmermann L; Zapf A; Elben S; Wojtecki L; Tucha O; Kalbe E
PLoS One; 2016; 11(7):e0159318. PubMed ID: 27437705
[TBL] [Abstract][Full Text] [Related]
3. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
[TBL] [Abstract][Full Text] [Related]
4. A parsimonious scoring and normative calculator for the Parkinson's disease mild cognitive impairment battery.
Bezdicek O; Sulc Z; Nikolai T; Stepankova H; Kopecek M; Jech R; Růžička E
Clin Neuropsychol; 2017; 31(6-7):1231-1247. PubMed ID: 28276860
[TBL] [Abstract][Full Text] [Related]
5. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia.
Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Antonini A
Parkinsonism Relat Disord; 2014 Apr; 20(4):394-9. PubMed ID: 24495708
[TBL] [Abstract][Full Text] [Related]
6. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
[TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
[TBL] [Abstract][Full Text] [Related]
10. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
[TBL] [Abstract][Full Text] [Related]
11. Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.
Bezdicek O; Michalec J; Nikolai T; Havránková P; Roth J; Jech R; Růžička E
Dement Geriatr Cogn Disord; 2015; 39(5-6):303-11. PubMed ID: 25792240
[TBL] [Abstract][Full Text] [Related]
12. Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.
Lucza T; Karádi K; Kállai J; Weintraut R; Janszky J; Makkos A; Komoly S; Kovács N
Behav Neurol; 2015; 2015():983606. PubMed ID: 26078489
[TBL] [Abstract][Full Text] [Related]
13. Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson's disease patients.
Sulzer P; Becker S; Maetzler W; Kalbe E; van Nueten L; Timmers M; Machetanz G; Streffer J; Salvadore G; Scholz E; Tkaczynska Z; Brockmann K; Berg D; Liepelt-Scarfone I
J Neurol; 2018 Sep; 265(9):1976-1984. PubMed ID: 29936665
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
Ozdilek B; Kenangil G
Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
[TBL] [Abstract][Full Text] [Related]
16. Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?
Erro R; Santangelo G; Barone P; Picillo M; Amboni M; Longo K; Giordano F; Moccia M; Allocca R; Pellecchia MT; Vitale C
J Geriatr Psychiatry Neurol; 2014 Dec; 27(4):276-81. PubMed ID: 24789732
[TBL] [Abstract][Full Text] [Related]
17. Home-Based Physical Behavior in Late Stage Parkinson Disease Dementia: Differences between Cognitive Subtypes.
Cerff B; Maetzler W; Sulzer P; Kampmeyer M; Prinzen J; Hobert MA; Blum D; van Lummel R; Del Din S; Gräber S; Berg D; Liepelt-Scarfone I
Neurodegener Dis; 2017; 17(4-5):135-144. PubMed ID: 28441649
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
Lawrence BJ; Gasson N; Loftus AM
Sci Rep; 2016 Sep; 6():33929. PubMed ID: 27650569
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
[TBL] [Abstract][Full Text] [Related]
20. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
Goldman JG; Holden S; Ouyang B; Bernard B; Goetz CG; Stebbins GT
Mov Disord; 2015 Mar; 30(3):402-6. PubMed ID: 25449653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
